Skip to content

Effect of 4 Weeks of Shuttle Run Training on Insulin Sensitivity in Sedentary Men

Effect of 4 Weeks of Shuttle Run Training on Insulin Sensitivity in Sedentary Men

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01962857
Enrollment
30
Registered
2013-10-14
Start date
2013-10-31
Completion date
2017-12-31
Last updated
2016-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance, Metabolic Syndrome, Obesity

Keywords

Physical activity, Exercise, Insulin resistance, High intensity interval training, Fat oxidation, Fitness, Lipids, Blood pressure

Brief summary

A number of studies have shown that short duration, high intensity interval training can improve health-related outcomes, such as insulin sensitivity and cardiorespiratory fitness. However, these often use specialized equipment, such as cycle ergometers, which makes it difficult to roll these interventions out for wide-scale use in the general population. This study aims evaluate the effects of a high intensity shuttle running intervention on insulin sensitivity, fitness and related cardiometabolic risk factors in men who are currently inactive. Participants will be randomized into intervention (4 weeks of shuttle running) and control groups. We hypothesize that the shuttle running programme will result in improved insulin sensitivity, fitness and increased fat oxidation at rest compared with the control group.

Interventions

BEHAVIORALExercise

4-week supervised high intensity shuttle running intervention, 3 sessions per week (12 sessions in total)

Sponsors

University of Glasgow
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* male * 18-40 years * undertaking \< 1 hour per week of planned exercise

Exclusion criteria

* BMI \> 35 kg/m2 * Blood pressure \> 160/90 mm Hg (on anti-hypertensive medication) * history of established coronary heart disease * family history of early cardiac death (\<40 years)

Design outcomes

Primary

MeasureTime frameDescription
Insulin sensitivityChange from baseline immediately post-intervention (4 weeks after baseline)Assessed from glucose and insulin concentrations in fasted state and during oral glucose tolerance test.

Secondary

MeasureTime frameDescription
Resting substrate utilizationChange from baseline immediately post-intervention (4 weeks after baseline)Metabolic rate and fat and carbohydrate oxidation estimated via indirect calorimetry
Endurance exercise performanceChange from baseline immediately post-intervention (4 weeks after baseline)Time taken to complete 100 x 10m shuttle runs
Sprint exercise performanceChange from baseline immediately post-intervention (4 weeks after baseline)Time taken to complete 10 x 10m shuttle runs
Waist circumferenceChange from baseline immediately post-intervention (4 weeks after baseline)
Percentage body fatChange from baseline immediately post-intervention (4 weeks after baseline)
Clustered Cardiometabolic Risk ScoreChange from baseline immediately post-intervention (4 weeks after baseline)Clustered Cardiometabolic Risk Score = -zHDL+zInsulin+zGlucose+zTriglycerides+( zBMI+zWC)/2+(zSBP+zDBP)/2.
Body weightChange from baseline immediately post-intervention (4 weeks after baseline)

Other

MeasureTime frameDescription
Objectively measured physical activityChange from baseline to week 4 of interventionTime spent sedentary and physically active assessed by accelerometer

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026